Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory

admin_news

Feb 13, 2026 - 21:30

0 0

Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

Stock market today: Dow, S&P 500, Nasdaq futures climb ...

admin_news Feb 27, 2025 0 0

Bitcoin ETFs Are Hit by a Record $1 Billion Outflow in ...

admin_news Feb 27, 2025 0 1

Super Micro Jumps After Filing Delayed Financial Reports

admin_news Feb 27, 2025 0 0

Nvidia Gives Mixed Outlook After Two Years of Blowout E...

admin_news Feb 27, 2025 0 0

Boeing Makes a Management Change. It Could Be Key to Pr...

admin_news Feb 27, 2025 0 0

Stock market today: Nasdaq, S&P 500 eke out gains as Do...

admin_news Feb 27, 2025 0 0

Comments

google.com, pub-7219625775647229, DIRECT, f08c47fec0942fa0